GlassScriptPhysician profile
Timothy P Shea
NPI 1366513707
$2,468.61
in general payments reported to CMS, 2019-2025
29 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $269 · 2021: $329 · 2022: $530 · 2023: $218 · 2024: $166 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,079.22 | 2019-2025 | Collagenase Santyl, Stravix Pl |
| Organogenesis INC. | $217.05 | 2019-2022 | |
| Polarityte, INC. | $133.60 | 2019-2021 | |
| Horizon Therapeutics Plc | $124.98 | 2019 | |
| Osiris Therapeutics INC. | $92.12 | 2019 | |
| Medela LLC | $74.77 | 2020 | |
| Nevro Corp. | $63.95 | 2022 | |
| Bioventus LLC | $62.25 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $61.78 | 2022 | |
| Mimedx Group, INC. | $57.48 | 2025 | |
| Glaxosmithkline, LLC. | $46.72 | 2025 | Shingrix, Arexvy |
| Tactile Systems Technology INC | $37.62 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Arthrosurface Incorporated | $37.50 | 2019 | |
| Orthofix Medical, INC. | $32.58 | 2023 | Physio-Stim |
| Globus Medical, INC. | $31.42 | 2025 | Senza |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $30.65 | 2020 | |
| Dexcom, INC. | $30.37 | 2025 | Dexcom G6 Transmitter |
| Grt US Holding, INC. | $27.72 | 2022 | |
| Sanofi-Aventis U.S. LLC | $27.19 | 2024 | |
| Fidia Pharma USA INC. | $24.05 | 2019 | |
| Amgen INC. | $22.89 | 2025 | Krystexxa |
| Genentech USA, INC. | $22.60 | 2025 | Xolair |
| Depuy Synthes Sales INC. | $21.27 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $20.69 | 2022 | |
| Integra Lifesciences Corporation | $19.91 | 2022 | |
| Xeris Pharmaceuticals, INC. | $19.74 | 2025 | Recorlev |
| Nabriva Therapeutics, Plc | $18.62 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $16.96 | 2022 | |
| Convatec INC. | $12.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.